Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.62 CHF | +0.18% | -2.05% | -5.15% |
07:35am | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
Feb. 16 | BB Biotech's Loss Narrows in FY23; Operating Income Down | MT |
Sales 2024 * | 190M 208M | Sales 2025 * | 101M 110M | Capitalization | 2.22B 2.44B |
---|---|---|---|---|---|
Net income 2024 * | 152M 167M | Net income 2025 * | 72M 78.95M | EV / Sales 2024 * | 13.2 x |
Net Debt 2024 * | 291M 319M | Net Debt 2025 * | 324M 356M | EV / Sales 2025 * | 25.3 x |
P/E ratio 2024 * |
14.6
x | P/E ratio 2025 * |
13.6
x | Employees | 10 |
Yield 2024 * |
5.8% | Yield 2025 * |
5.92% | Free-Float | 97.24% |
1 day | +0.18% | ||
1 week | -2.05% | ||
Current month | -10.98% | ||
1 month | -10.58% | ||
3 months | -8.05% | ||
6 months | +12.17% | ||
Current year | -5.15% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Koller
CIO | Chief Investment Officer | 54 | 03-12-31 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Meanwell
BRD | Director/Board Member | 67 | 03-12-31 |
Director/Board Member | 63 | 19-12-31 | |
Chairman | 63 | 19-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 40.55 | 0.00% | 11 732 |
24-04-25 | 40.55 | -2.17% | 59,657 |
24-04-24 | 41.45 | -0.36% | 57,148 |
24-04-23 | 41.6 | +0.97% | 113,601 |
24-04-22 | 41.2 | -0.48% | 63,519 |
Delayed Quote Swiss Exchange, April 26, 2024 at 04:50 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.15% | 2.44B | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.36% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- BION Stock